Message Board

Respected readers, authors and reviewers, you can add comments to this page on any questions about the contribution, review,        editing and publication of this journal. We will give you an answer as soon as possible. Thank you for your support!

Name
E-mail
Phone
Title
Content
Verification Code
x Close Forever Close
Volume 37 Issue 4
. 
Turn off MathJax
Article Contents
Article Navigation >  Journal of Pharmaceutical Practice and Service  > 2019  >  37(4): 375-379

RUAN Jun, YIN Heng, KOU Guoxian, LIU Mingxin, YANG Ruixi. A Meta-analysis on magnesium isoglycyrrhizinate in treatment of antituberculosis drug-induced liver injury[J]. Journal of Pharmaceutical Practice and Service, 2019, 37(4): 375-379. doi: 10.3969/j.issn.1006-0111.2019.04.018
Citation: RUAN Jun, YIN Heng, KOU Guoxian, LIU Mingxin, YANG Ruixi. A Meta-analysis on magnesium isoglycyrrhizinate in treatment of antituberculosis drug-induced liver injury[J]. Journal of Pharmaceutical Practice and Service, 2019, 37(4): 375-379. doi: 10.3969/j.issn.1006-0111.2019.04.018
shu

A Meta-analysis on magnesium isoglycyrrhizinate in treatment of antituberculosis drug-induced liver injury

doi: 10.3969/j.issn.1006-0111.2019.04.018
  • 1.

    Sichuan Mianyang Central Hospital, Department of infectious, Mianyang 621000, China

  • 2.

    Sichuan Mianyang Central Hospital, Department of nephrology, Mianyang 621000, China

  • Received Date: 2019-01-30
  • Rev Recd Date: 2019-05-14
  • Objective To evaluate the therapeutic effects of magnesium isoglycyrrhizinate in patients with antituberculosis drug-induced liver injury. Methods The literatures related to randomized controlled trials (RCT) of magnesium isoglycyrrhizinate treatment in patients with antituberculosis drug-induced liver injury were retrieved from CNKI,VIP,WanFang database,PubMed,EMbase and Cochrane Library.The collected literatures were published before April 2019.Based on the inclusive and exclusive criteria,the literatures were screened,and data were extracted by two researchers independently.Meanwhile the quality of the included studies was assessed.Meta-analysis was conducted by RevMan 5.2 software. Results 823 patients with antituberculosis drug-induced liver injury in ten RCT were enrolled.The meta-analysis demonstrated,a) compared with control group,the early-stage administration of magnesium isoglycyrrhizinate can effectively treat liver injury caused by antituberculosis drugs with statistical significance,and b) magnesium isoglycyrrhizinate can significantly reduce the alanine aminotransferase level and improve the total bilirubin level during the treatment. Conclusion Magnesium isoglycyrrhizinate administration is an effective treatment for liver injury caused by antituberculosis drugs although more high-quality researches are needed for further verification.
  • [1] 中华医学会肝病学分会药物性肝病学组.药物性肝损伤诊治指南[J].临床肝胆病杂志,2015,31(11):1752-1769.
    [2] LI L,JIANG W,WANG J Y.Clinical analysis of 275 cases of acute drug-induced liver disease[J].Front Med China,2007,1(1):58-61.
    [3] BJÖRNSSON E S.Epidemiology and risk factors for idiosyncratic drug-induced liver injury[J].Semin Liver Dis,2014,34(2):115-122.
    [4] WHO.Global Tuberculosis Report2017[R/OL].2017-12[2018-02-18].
    [5] ZHANG S M,PAN H Q,PENG X Z,et al.Preventive use of a hepatoprotectant against anti-tuberculosis drug-induced liver injury:A randomized controlled trial[J].J Gastroenterol Hepatol,2016,31(2):409-416.
    [6] CHANG T E,HUANG Y S,CHANG C H,et al.The susceptibility of anti-tuberculosis drug-induced liver injury and chronic hepatitis C infection:A systematic review and meta-analysis[J].J Chin Med Assoc,2018,81(2):111-118.
    [7] 李仁仙.异甘草酸镁治疗药物性肝炎50例临床分析[J].亚太传统医药,2011,7(8):75-76.
    [8] 付贵化,朱红辉,陈红艳.异甘草酸镁治疗结核药物引起药物性肝炎临床观察[J].医药前沿,2012,2:132-133.
    [9] 高卫红,邵伟杰,雷涛.异甘草酸镁治疗抗结核药物性肝损伤45例[J].中国药业,2013,22(11):122-123.
    [10] 邓敏,宣华,余晓,等.异甘草酸镁联合谷胱甘肽治疗抗结核药物所致中度以上肝损害疗效观察[J].浙江实用医学,2013,18(3):177-178.
    [11] 郭新枝,陈裕,程俊伟,等.异甘草酸镁注射液治疗抗结核药物所致急性肝损伤的临床研究[J].微生物与感染,2013,8(3):157-162.
    [12] 田红华,汪水香.异甘草酸镁治疗抗结核药物引起的药物性肝炎临床疗效观察[J].医药前沿,2014,12:26-27.
    [13] 陈永芳,程俊伟,陈裕,等.异甘草酸镁注射液治疗抗结核药物所致急性肝损伤的疗效分析[J].北京医学,2014,36(3):223-225.
    [14] 熊延军,李东方,孙红,等.异甘草酸镁治疗抗结核药物性肝损害的效果分析[J].中国当代医药,2014,21(5):68-69,72.
    [15] 吴小霞,辛朝雄,李晓云,等.异甘草酸镁治疗抗结核药引起的药物性肝炎的疗效分析[J].现代诊断与治疗,2015,26(6):1272-1274.
    [16] 白龙.异甘草酸镁治疗结核药物性肝损害的疗效观察[J].临床医药文献杂志,2015,2(27):5724-5726.
    [17] LIMAMD E F,MELO H R.Hepatotoxicity induced by antituberculosis drugs among patients coinfected with HIV and tuberculosis[J].Cad Saude Publica,2012,28(4):698-708.
    [18] RANGNEKAR A S,FONTANA R J.An update on drug induced liver injury[J].Minerva Gastroenterol Dietol,2011,57(2):213-229.
    [19] MANNS M P,WEDEMEYER H,SINGER A,et al.Glycyrrhizin in patients who failed previous interferon alpha-based therapies:biochemical and histological effects after 52 weeks[J].J Viral Hepat,2012,19(8):537-546.
  • 加载中
通讯作者: 陈斌, bchen63@163.com
  • 1. 

    沈阳化工大学材料科学与工程学院 沈阳 110142

  1. 本站搜索
  2. 百度学术搜索
  3. 万方数据库搜索
  4. CNKI搜索
Get Citation
PDF
XML

Article Metrics

Article views(2857) PDF downloads(723) Cited by()

Related
Proportional views

A Meta-analysis on magnesium isoglycyrrhizinate in treatment of antituberculosis drug-induced liver injury

doi: 10.3969/j.issn.1006-0111.2019.04.018
  • 1. Sichuan Mianyang Central Hospital, Department of infectious, Mianyang 621000, China
  • 2. Sichuan Mianyang Central Hospital, Department of nephrology, Mianyang 621000, China
  • Received Date: 2019-01-30
  • Rev Recd Date: 2019-05-14

Abstract: Objective To evaluate the therapeutic effects of magnesium isoglycyrrhizinate in patients with antituberculosis drug-induced liver injury. Methods The literatures related to randomized controlled trials (RCT) of magnesium isoglycyrrhizinate treatment in patients with antituberculosis drug-induced liver injury were retrieved from CNKI,VIP,WanFang database,PubMed,EMbase and Cochrane Library.The collected literatures were published before April 2019.Based on the inclusive and exclusive criteria,the literatures were screened,and data were extracted by two researchers independently.Meanwhile the quality of the included studies was assessed.Meta-analysis was conducted by RevMan 5.2 software. Results 823 patients with antituberculosis drug-induced liver injury in ten RCT were enrolled.The meta-analysis demonstrated,a) compared with control group,the early-stage administration of magnesium isoglycyrrhizinate can effectively treat liver injury caused by antituberculosis drugs with statistical significance,and b) magnesium isoglycyrrhizinate can significantly reduce the alanine aminotransferase level and improve the total bilirubin level during the treatment. Conclusion Magnesium isoglycyrrhizinate administration is an effective treatment for liver injury caused by antituberculosis drugs although more high-quality researches are needed for further verification.

RUAN Jun, YIN Heng, KOU Guoxian, LIU Mingxin, YANG Ruixi. A Meta-analysis on magnesium isoglycyrrhizinate in treatment of antituberculosis drug-induced liver injury[J]. Journal of Pharmaceutical Practice and Service, 2019, 37(4): 375-379. doi: 10.3969/j.issn.1006-0111.2019.04.018
Citation: RUAN Jun, YIN Heng, KOU Guoxian, LIU Mingxin, YANG Ruixi. A Meta-analysis on magnesium isoglycyrrhizinate in treatment of antituberculosis drug-induced liver injury[J]. Journal of Pharmaceutical Practice and Service, 2019, 37(4): 375-379. doi: 10.3969/j.issn.1006-0111.2019.04.018
shu

    HTML

Reference (19)

Catalog

    版权所有：《药学实践与服务》编辑委员会

    Supervisor & Sponsors: Address: No 325 Guohe Road, ShanghaiPost Code: 200433

    Tel: （021）81871324,81871397 E-mail: yxsjzzs@163.com

    网站备案号 沪ICP备05003363号-1

    Supported by: Beijing Renhe Information Technology Co., Ltd.  

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return